Sex specific efficacy and safety outcomes in operable stage III non-small cell lung cancer (NSCLC): Pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14

被引：0
|
作者：
Frehner, L. [1 ]
Schaer, S. [2 ]
Hayoz, S. [2 ]
Guckenberger, M. [3 ]
Finazzi, T. [4 ]
Mark, M. T. [5 ]
Addeo, A. [6 ]
Mauti, L. A. [7 ]
Betticher, D. C. [8 ]
Stupp, R. [9 ]
Curioni-Fontecedro, A. [10 ]
Peters, S. [11 ]
Frueh, M. [12 ]
Rothschild, S. I. [13 ,14 ]
Pless, M.
Koenig, D. [15 ]
Schmitt-Opitz, I. [16 ]
Ris, H-B. [17 ]
Ozdemir, B. C. [1 ]
Schmid, S. [1 ]
机构：
[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Med Oncol, Bern, Switzerland
[2] Swiss Grp Clin Canc Res SAKK Competence Ctr, Stat, Bern, Switzerland
[3] Univ Zurich, Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[4] Univ Hosp Basel, Clin Radiotherapy & Radiat Oncol, Basel, Switzerland
[5] Cantonal Hosp Graubuenden, Div Hematol Oncol, Chur, Switzerland
[6] Univ Hosp Geneva, Dept Oncol, Geneva, Switzerland
[7] Kantonsspital Winterthur, Dept Med Oncol, Winterthur, Switzerland
[8] Univ Fribourg, Cantonal Hosp Fribourg, Clin Oncol, Villars Sur Glane, Switzerland
[9] Northwestern Univ, Feinberg Sch Med, Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[10] Univ Fribourg, Cantonal Hosp Fribourg, Clin Oncol, Villar Sur Glane, Switzerland
[11] Ctr Hosp Univ Vaudois CHUV, Dept Oncol, Lausanne, Switzerland
[12] Kantonsspital St Gallen, Dept Med Oncol & Hematol, St Gallen, Switzerland
[13] Cantonal Hosp Baden, Ctr Oncol Hematol, Baden, Switzerland
[14] Cantonal Hosp Baden, Ctr Comprehens Canc, Baden, Switzerland
[15] Univ Hosp Basel, Dept Med Oncol, Basel, Switzerland
[16] Univ Zurich, Univ Zurich Hosp, Dept Thorac Surg, Zurich, Switzerland
[17] Hop Valais, Clin Thorac Surg, Sion, Switzerland
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1282
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1223P
引用
收藏
页码：S786 / S786
页数：1
相关论文
共 50 条
  • [31] CYCLOPHOSPHAMIDE, VINDESINE AND ORAL VP-16 IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER (NSCLC) - AN OUTPATIENT REGIMEN
    WEITBERG, AB
    CHEMOTHERAPY, 1988, 34 (02) : 155 - 157
  • [32] A phase II study of neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage III unresectable non-small cell lung cancer
    Iacobelli, S
    Irtelli, L
    Sacco, R
    Martino, M
    Mascitelli, E
    Basilico, L
    Scognamiglio, M
    Natoli, C
    Fusco, O
    Tinari, N
    Beltrami, V
    ANTICANCER RESEARCH, 1998, 18 (3B) : 2081 - 2084
  • [33] Results of phase III trial of rh-endostatin (YH-16) in advanced non-small cell lung cancer (NSCLC) patients.
    Sun, Y
    Wang, J
    Liu, Y
    Song, X
    Zhang, Y
    Li, K
    Zhu, Y
    Zhou, Q
    You, L
    Yao, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 654S - 654S
  • [34] The cathelicidin-BF Lys16 mutant Cbf-K16 selectively inhibits non-small cell lung cancer proliferation in vitro
    Tian, Yuwei
    Wang, Hui
    Li, Bing
    Ke, Mengyun
    Wang, Jing
    Dou, Jie
    Zhou, Changlin
    ONCOLOGY REPORTS, 2013, 30 (05) : 2502 - 2510
  • [35] Randomized phase III study comparing the efficacy and safety of CT-P16, a new biosimilar, to reference bevacizumab (Avastin®) in patients with metastatic or recurrent non-small cell lung cancer (NSCLC)
    Ohe, Yuichiro
    Bondarenko, Igor
    Andric, Zoran
    Ostapenko, Yuriy
    Ciuleanu, Tudor
    Moiseenko, Fedor
    Makharadze, Tamta
    Shevnya, Sergii
    Oleksiienko, Alona
    Yanez Ruiz, Eduardo
    Kim, SungHyun
    Ahn, KeumYoung
    Park, TaeHong
    Park, Sijin
    Lee, Jieun
    Kim, Minji
    Verschraegen, Claire
    CANCER RESEARCH, 2022, 82 (12)
  • [36] Inflammatory phenotype of classical (CD14++CD16-) monocytes in patients with advanced non-small cell lung cancer
    McCarthy, Fiona Margaret
    Ghirelli, Cristina
    Zollinger, Raphael
    Phillips, Melissa
    Roshani, Rozita
    Candido, Juliana
    Trehy, Roisin
    Sheaff, Michael
    Steele, Jeremy
    Hagemann, Thorsten
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER WITH INFUSIONAL VP-16 AND CISPLATINUM
    VALDIVIESO, M
    WOZNIAK, A
    BAKER, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 217 - 217
  • [38] P16 Methylation Leads to Paclitaxel Resistance of Advanced Non-Small Cell Lung Cancer
    Liu, Zhaojun
    Lin, Hongmei
    Gan, Ying
    Cui, Chenghua
    Zhang, Baozhen
    Gu, Liankun
    Zhou, Jing
    Zhu, Guangying
    Deng, Dajun
    JOURNAL OF CANCER, 2019, 10 (07): : 1726 - 1733
  • [39] Hypermethylation of p16INK4a in Korean non-small cell lung cancer patients
    Hong, Young-Seoub
    Roh, Mee-Sook
    Kim, Na-Young
    Lee, Hye-Jung
    Kim, Hee-Kyoung
    Lee, Kyung-Eun
    Kwak, Jong-Young
    Kim, Joon-Youn
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 : S32 - S37
  • [40] Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer
    Xiao, Ping
    Chen, Jian-rong
    Zhou, Feng
    Lu, Chen-xi
    Yang, Qichan
    Tao, Guo-hua
    Tao, Yi-jiang
    Chen, Jing-liang
    LUNG CANCER, 2014, 83 (01) : 56 - 60
12345